Furosemide Tablets
Awarded on December 8, 2021. Full description on SAM.gov.
Overview
- Posted
- November 25, 2025
- Notice type
- Award Notice
- NAICS
- 325412: Pharmaceutical Preparation Manufacturing
- Agency
- Department of WarDEFENSE LOGISTICS AGENCY
Notice details
- Office
- TROOP SUPPORT MEDICAL.DLA TROOP SUPPORT
- Place of performance
- Charlotte, North Carolina, 28206
- PSC
- 6505: DRUGS AND BIOLOGICALS
- Last updated
- Oct 28, 2026
- First published
- Last updated on SAM.gov
- Award date
- Dec 8, 2021
- Award amount (SAM.gov award notice)
- $16.7M
Identifiers
- Solicitation number
- SPE2D221R0110
- Notice ID
- 6193c84fe0de4750843eeca7032d6619
- Award number (PIID)
- SPE2D222D0140
Description
SPE2D2-22-D-0140 P00008 to exercise Option Year 4 effective December 08, 2025 through December 07, 2026.
SPE2D2-22-D-0140 P00007 is modified in accordance with DoD Class Deviation 2025-O0003.
SPE2D2-22-D-0140 P00006 to exercise Option Year 3 effective December 08, 2024 through December 07, 2025.
SPE2D2-22-D-0140 P00005 is issued to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders into subject solicitation.
SPE2D2-22-D-0140 P00004 to exercise Option Year 2 effective December 08, 2023 through December 07, 2024.
SPE2D2-22-D-0140 P00003 to incorporate Drug Supply Chain Act (DSCA) language into solicitation for subject contract.
SPE2D2-22-D-0140 P00002 to Incorporate FAR 52.204-27 Prohibituion on a Bytedance Covered Application (June 2023) into contract.
Invocation of Option Year 1 Modification P00001 SPE2D2-22-D-0140
Contract Award for Furosemide Tablets SPE2D222D0140
Award Overview
Award Number
SPE2D222D0140
Award Amount (SAM.gov award notice)
$16.7M
Award Date
Dec 8, 2021
Awardee
Awardee UEI
SFPGXE6XPS93
Awardee CAGE Code
4QGW8
Awardee Address
Pulaski, TN 38478, UNITED STATES
Original Solicitation
Notice ID: 6193c84fe0de4750843eeca7032d6619
Posted Date: Nov 25, 2025
Original Response Deadline: Not specified
Contacts
Contracting Officer
Primary Contact
Secondary Contact
Documents
Files (10)
- Download
Modification P00008 SPE2D222D0140 Option Year 4.PDF
25 KBAdded in Award Notice version 7Posted - Download
Modification P00007 SPE2D222D0140.PDF
196 KBAdded in Award Notice version 7Posted - Download
Option Year 3 Modification P00006 SPE2D222D0140.PDF
25 KBAdded in Award Notice version 6Posted - Download
Modification P00005 SPE2D222D0140.PDF
188 KBAdded in Award Notice version 6Posted - Download
Option Year 2 Modification P00004 SPE2D2-22-D-0140.pdf
25 KBAdded in Award Notice version 5Posted - Download
Signed SPE2D222D0140 P00003 Furosemide.pdf
267 KBAdded in Award Notice version 4Posted - Download
SF30_SPE2D222D0140P00002.PDF
173 KBAdded in Award Notice version 4Posted - Download
Option Year 1 Modification P00001 SPE2D2-22-D-0140.PDF
25 KBAdded in Award Notice version 3Posted - Download
Signed Furosemide SPE2D222D0140.pdf
1.3 MBAdded in Award Notice version 2Posted - Download
Furosemide Solicitation SPE2D2-21-R-0110.pdf
1.6 MBAdded in Solicitation version 2Posted
Lifecycle
- 1
- 2Version 2Award Notice
Type changed from Solicitation to Award Notice
Furosemide Tablets
- 3
- 4
- 5
- 6
- 7
Similar Opportunities
Additional Details
Solicitation Number
SPE2D221R0110
Archive Date
Dec 7, 2026
Office Address
PHILADELPHIA, PA, 19111